carboplatin plus nab-paclitaxel

2 trials

Sponsors

St. Marianna University School of Medicine, Shizuoka cancer center

Conditions

Non-small-cell lung cancercompletely resected pathological stage II/IIIA non-small cell lung cancer

Phase 1

Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2

RecruitingJPRN-UMIN000014544

Shizuoka cancer centerNon-small-cell lung cancer

Start: 2014-07-14Target: 33Updated: 2026-06-29

Unknown Phase

Feasibility study of postoperative adjuvant carboplatin plus nab-paclitaxel for complete resected pathological stage II/IIIA non-small cell lung cancer

Active, not recruitingJPRN-UMIN000011225

St. Marianna University School of Medicinecompletely resected pathological stage II/IIIA non-small cell lung cancer

Start: 2013-07-22Target: 35Updated: 2026-06-29

Related Papers

Feasibility study of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected non-small-cell lung cancer

Anti-Cancer Drugs2017-05-193 citations